2014 -- H 7903 SUBSTITUTE A | |
======== | |
LC005075/SUB A | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2014 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE | |
| |
Introduced By: Representatives Hull, Bennett, Ajello, Naughton, and Ferri | |
Date Introduced: March 11, 2014 | |
Referred To: House Corporations | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 27-18-70 of the General Laws in Chapter 27-18 entitled "Accident |
2 | and Sickness Insurance Policies" is hereby amended to read as follows: |
3 | 27-18-70. Enteral nutrition products. -- (a) Every individual or group health insurance |
4 | contract, or every individual or group hospital or medical expense insurance policy, plan, or |
5 | group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009, |
6 | shall provide coverage for nonprescription enteral formulas for home use for which a physician |
7 | has issued a written order and which that are medically necessary for the treatment of |
8 | malabsorption caused by Crohn's disease, ulcerative colitis, gastroesophageal reflux, chronic |
9 | intestinal pseudo- obstruction, and inherited diseases of amino acids and organic acids. Coverage |
10 | for inherited diseases of amino acids and organic acids shall include food products modified to be |
11 | low protein and shall extend to all recipients regardless of age. Provided, however, that coverage |
12 | shall not exceed an amount of two thousand five hundred dollars ($2,500) per covered member |
13 | per year. |
14 | (b) Benefit plans offered by an insurer may impose a copayment and/or deductibles for |
15 | the benefits mandated by this section, however, in no instance shall the copayment or deductible |
16 | amount be greater than the copayment or deductible amount imposed for prescription enteral |
17 | formulas or nutritional aids. Benefits for services under this chapter shall be reimbursed in |
18 | accordance with the respective principles and mechanisms of reimbursement for each insurer, |
19 | hospital, or medical service corporation, or health maintenance organization. Reimbursement |
| |
1 | shall be provided according to the respective principles and policies of the accident and sickness |
2 | insurer. Nothing contained in this section precludes the accident and sickness insurer from |
3 | conducting managed care, medical necessity, or utilization review. |
4 | (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital |
5 | confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term care; (5) |
6 | Medicare supplement; (6) lLimited benefit health; (7) sSpecified disease indemnity; (8) sSickness |
7 | or bodily injury or death by accident or both; and (9) oOther limited-benefit policies. |
8 | SECTION 2. Section 27-19-61 of the General Laws in Chapter 27-19 entitled "Nonprofit |
9 | Hospital Service Corporations" is hereby amended to read as follows: |
10 | 27-19-61. Enteral nutrition products. -- (a) Every individual or group health insurance |
11 | contract, or every individual or group hospital or medical expense insurance policy, plan, or |
12 | group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009, |
13 | shall provide coverage for nonprescription enteral formulas for home use for which a physician |
14 | has issued a written order and which that are medically necessary for the treatment of |
15 | malabsorption caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic |
16 | intestinal pseudo-obstruction, and inherited diseases of amino acids and organic acids. Coverage |
17 | for inherited diseases of amino acids and organic acids shall include food products modified to be |
18 | low protein and shall extend to all recipients regardless of age. Provided, however, that coverage |
19 | shall not exceed an amount of two thousand five hundred dollars ($2,500) per covered member |
20 | per year. |
21 | (b) Benefit plans offered by a hospital service corporation may impose a copayment |
22 | and/or deductible for the benefits mandated by this section, however, in no instance shall the |
23 | copayment or deductible amount be greater than the copayment or deductible amount imposed for |
24 | prescription enteral formulas or nutritional aids. Benefits for services under this chapter shall be |
25 | reimbursed in accordance with the respective principles and mechanisms of reimbursement for |
26 | each insurer, hospital, or medical service corporation, or health maintenance organization. |
27 | Reimbursement shall be provided according to the respective principles and policies of the |
28 | accident and sickness insurer. Nothing contained in this section precludes the accident and |
29 | sickness insurer from conducting managed care, medical necessity, or utilization review. |
30 | (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital |
31 | confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term care; (5) |
32 | Medicare supplement; (6) lLimited benefit health; (7) sSpecified disease indemnity; (8) sSickness |
33 | or bodily injury or death by accident or both; and (9) oOther limited-benefit policies. |
34 | SECTION 3. Section 27-20-56 of the General Laws in Chapter 27-20 entitled "Nonprofit |
| LC005075/SUB A - Page 2 of 7 |
1 | Medical Service Corporations" is hereby amended to read as follows: |
2 | 27-20-56. Enteral nutrition products. -- (a) Every individual or group health insurance |
3 | contract, or every individual or group hospital or medical expense insurance policy, plan, or |
4 | group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009, |
5 | shall provide coverage for nonprescription enteral formulas for home use for which a physician |
6 | has issued a written order and which that are medically necessary for the treatment of |
7 | malabsorption caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic |
8 | intestinal pseudo-obstruction, and inherited diseases of amino acids and organic acids. Coverage |
9 | for inherited diseases of amino acids and organic acids shall include food products modified to be |
10 | low protein and shall extend to all recipients regardless of age. Provided, however, that coverage |
11 | shall not exceed an amount of two thousand five hundred dollars ($2,500) per covered member |
12 | per year. |
13 | (b) Benefit plans offered by a medical service corporation may impose a copayment |
14 | and/or deductible for the benefits mandated by this section, however, in no instance shall the |
15 | copayment or deductible amount be greater than the copayment of deductible amount imposed for |
16 | prescription enteral formulas or nutritional aids. Benefits for services under this chapter shall be |
17 | reimbursed in accordance with the respective principles and mechanisms of reimbursement for |
18 | each insurer, hospital, or medical service corporation, or health maintenance organization. |
19 | Reimbursement shall be provided according to the respective principles and policies of the |
20 | accident and sickness insurer. Nothing contained in this section precludes the accident and |
21 | sickness insurer from conducting managed care, medical necessity, or utilization review. |
22 | (c) This section shall not apply to insurance coverage providing benefits for: (1) hospital |
23 | confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term care; (5) |
24 | Medicare supplement; (6) lLimited benefit health; (7) sSpecified disease indemnity; (8) sSickness |
25 | or bodily injury or death by accident or both; and (9) oOther limited-benefit policies. |
26 | SECTION 4. Section 27-41-74 of the General Laws in Chapter 27-41 entitled "Health |
27 | Maintenance Organizations" is hereby amended to read as follows: |
28 | 27-41-74. Enteral nutrition products. -- (a) Every individual or group health insurance |
29 | contract, or every individual or group hospital or medical expense insurance policy, plan, or |
30 | group policy delivered, issued for delivery, or renewed in this state on or after January 1, 2009, |
31 | shall provide coverage for nonprescription enteral formulas for home use for which a physician |
32 | has issued a written order and which that are medically necessary for the treatment of |
33 | malabsorption caused by Crohn's disease, ulcerative colitis, gastroespphageal reflux, chronic |
34 | intestinal pseudo-obstruction, and inherited diseases of amino acids and organic acids. Coverage |
| LC005075/SUB A - Page 3 of 7 |
1 | for inherited diseases of amino acids and organic acids shall include food products modified to be |
2 | low protein and shall extend to all recipients regardless of age. Provided, however, that coverage |
3 | shall not exceed an amount of two thousand five hundred dollars ($2,500) per covered member |
4 | per year. |
5 | (b) Benefit plans offered by a health maintenance organization may impose a copayment |
6 | and/or deductible for the benefits mandated by this section, however, in no instance shall the |
7 | copayment or deductible amount be greater than the copayment of deductible amount imposed for |
8 | prescription enteral formulas or nutritional aids. Benefits for services under this chapter shall be |
9 | reimbursed in accordance with the respective principles and mechanisms of reimbursement for |
10 | each insurer, hospital, or medical service corporation, or health maintenance organization. |
11 | Reimbursement shall be provided according to the respective principles and policies of the |
12 | accident and sickness insurer. Nothing contained in this section precludes the accident and |
13 | sickness insurer from conducting managed care, medical necessity, or utilization review. |
14 | (c) This section shall not apply to insurance coverage providing benefits for: (1) |
15 | hHospital confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term |
16 | care; (5) Medicare supplement; (6) lLimited benefit health; (7) sSpecified disease indemnity; (8) |
17 | sSickness or bodily injury or death by accident or both; and (9) oOther limited-benefit policies. |
18 | SECTION 5. Section 40-6-3.12 of the General Laws in Chapter 40-6 entitled "Public |
19 | Assistance Act" is hereby amended to read as follows: |
20 | 40-6-3.12. Enteral nutrition products. -- (a) As used in this section: |
21 | (1) "Enteral nutrition" means a supplemental feeding that is provided via the |
22 | gastrointestinal tract by mouth (orally), or through a tube, catheter, or stoma that delivers |
23 | nutrients distal to the oral cavity. |
24 | (2) "Nutritional risk" means actual or potential for developing malnutrition, as evidenced |
25 | by clinical indicators, the presence of chronic disease, or increased metabolic requirements due to |
26 | impaired ability to ingest or absorb food adequately. |
27 | (b) The department shall provide for vendor payment of enteral nutrition products in |
28 | accordance with rules and regulations of the department, when determined to be medically |
29 | necessary on an individual, case-by-case basis and ordered by a physician in accordance with |
30 | Rhode Island department of health form(s) on enteral nutrition products. Provided, however, that |
31 | coverage shall not exceed an amount of two thousand five hundred dollars ($2,500) per individual |
32 | per year. |
33 | (c) Protocols for the use of enteral nutrition as a medically necessary treatment for |
34 | malabsorption caused by Crohn’s disease, ulcerative colitis, gastroesophageal reflux, chronic |
| LC005075/SUB A - Page 4 of 7 |
1 | intestinal pseudo-obstruction, and inherited diseases of amino acids and organic acids may be |
2 | developed by the director. The determination of medical necessity for enteral nutrition products |
3 | shall be based upon a combination of clinical data and the presence of indicators that would affect |
4 | the relative risks and benefits of the products including, but not limited to: |
5 | (1) Enteral nutrition, whether orally or by tube feeding, is used as a therapeutic regimen |
6 | to prevent serious disability or death in a person with a medically diagnosed condition that |
7 | precludes the full use of regular food. |
8 | (2) The person presents clinical signs and symptoms of impaired digestion |
9 | malabsorption, or nutritional risk, as indicated by the following anthropometric measures: |
10 | (i) Weight loss that presents actual or potential for developing, malnutrition as follows: |
11 | (A) In adults, showing involuntary or acute weight loss of greater than or equal to ten |
12 | percent (10%) of usual body weight during a three (3) to six- (6) month (6) period, or body mass |
13 | index (bmi) below 18.5 kg/m2; |
14 | (B) In neonates, infants and children, showing: |
15 | (I) Very low birth weight (lbw), even in the absence of gastrointestinal, pulmonary, or |
16 | cardiac disorders; |
17 | (II) A lack of weight gain, or weight gain less than two (2) standard deviations below the |
18 | age appropriate mean in a one month period for children under six (6) months, or two (2) month |
19 | period for children aged six (6) to twelve (12) months; |
20 | (III) No weight gain or abnormally slow rate of gain for three (3) months for children |
21 | older than one year, or documented weight loss that does not reverse promptly with instruction in |
22 | appropriate diet for age; or |
23 | (IV) Weight for height less than the tenth (10th) percentile; and |
24 | (ii) Abnormal laboratory test pertinent to the diagnosis. |
25 | (3) The risk factors for actual or potential malnutrition have been identified and |
26 | documented. Such risk factors include, but are not limited to, the following: |
27 | (i) Anatomic structures of the gastrointestinal tract that impair digestion and absorption; |
28 | (ii) Neurological disorders that impair swallowing or chewing; |
29 | (iii) Diagnosis of inborn errors of metabolism that require medically necessary formula |
30 | used for specific metabolic conditions and food products modified low in protein (for example, |
31 | phenylketonuria (pku) tyrosinemia, homocystinuria, maple syrup urine disease, propionic aciduria |
32 | and methylmalonic aciduria); |
33 | (iv) Prolonged nutrient losses due to malabsorption syndromes or short-bowel |
34 | syndromes, diabetes, celiac disease, chronic pancreatitis, renal dialysis, draining abscess or |
| LC005075/SUB A - Page 5 of 7 |
1 | wounds, etc.; |
2 | (v) Treatment with anti-nutrient or catabolic properties (for example, anti-tumor |
3 | treatments, corticosteroids, immunosuppressant, etc.); |
4 | (vi) Increased metabolic and/or caloric needs due to excessive burns, infection, trauma, |
5 | prolonged fever, hyperthyroidism, or illnesses that impair caloric intake and/or retention; or |
6 | (vii) A failure-to-thrive diagnosis that increases caloric needs while impairing caloric |
7 | intake and/or retention. |
8 | (4) A comprehensive medical history and a physical examination have been conducted to |
9 | detect factors contributing to nutritional risk. |
10 | (5) Enteral nutrition is indicated as the primary source of nutritional support essential for |
11 | the management of risk factors that impair digestion or malabsorption, and for the management of |
12 | surgical preparation or postoperative care. |
13 | (6) A written plan of care has been developed for regular monitoring of signs and |
14 | symptoms to detect improvement in the person's condition. Nutritional status should be monitored |
15 | regularly; |
16 | (i) For improvements in anthropometric measures; |
17 | (ii) For improvements in laboratory test indicators; and |
18 | (iii) In children, to assess growth and weight for height. |
19 | (d) Enteral nutrition products shall not be considered medically necessary under certain |
20 | circumstances including, but not limited to, the following: |
21 | (1) A medical history and physical examination have been performed and other possible |
22 | alternatives have been identified to minimize nutritional risk. |
23 | (2) The person is underweight, but has the ability to meet nutritional needs through the |
24 | use of regular food consumption. |
25 | (3) Enteral products are used as supplements to a normal or regular diet in a person |
26 | showing no clinical indicators of nutritional risk. |
27 | (4) The person has food allergies, lactose intolerance or dental problems, but has the |
28 | ability to meet his or her nutritional requirements through an alternative food source. |
29 | (5) Enteral products are to be used for dieting or a weight-loss program. |
30 | (6) No medical history or physical examination has been taken and there is no |
31 | documentation that supports the need for enteral nutrition products. |
32 | SECTION 6. This act shall take effect upon passage. |
======== | |
LC005075/SUB A | |
======== | |
| LC005075/SUB A - Page 6 of 7 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE | |
*** | |
1 | This act would require insurance coverage of formula and other prescribed food for all |
2 | patients regardless of age, and would also abolish the mandated cap on coverage. |
3 | This act would take effect upon passage. |
======== | |
LC005075/SUB A | |
======== | |
| LC005075/SUB A - Page 7 of 7 |